Obesity and cardiovascular disease: Expected and unexpected relationship;Obesità e patologie cardiovascolari: Relazioni attese ed inattese

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 64, Issue 1, 2005, Pages 38-41

  Pedone, Chiara ^a   Urbinati, Stefano ^a   Pallotti, Maria Giovanna ^a   Pinelli, Giuseppe ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

Cardiovascular disease; Cardiovascular risk; Obesity

Indexed keywords

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLOW UP; HEART INFARCTION; HEART SURGERY; HIGH RISK POPULATION; HUMAN; MORTALITY; OBESITY; PROGNOSIS; RISK FACTOR;

EID: 23844487579     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2005.610     Document Type: Article

References (37)

1. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-1727.
2. Ogden CL, Flegal KM, Carrol MD, Johonson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732.
3. Obesity: prevention and management of the global epidemic. Report of a WHO consultation. Thecnical Report Series 2000. ISBN 92 4 120894 5.
4. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to Obesity. JAMA 289: 187-193.
5. Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA 2003; 289: 229-230.
6. Allison DB, Fontaine KR, Manson JE, Stenvens J, VanItallie TB. Annual death attributable to obesity in United States. JAMA 1999; 282: 1530-1538.
7. Sturm R, Wells KB. Does obesity contribute as much as to morbility as poverty or smoking? Public Health 2001; 115: 229-235.
8. Manson JE, Willet WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
9. Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldamn L. Body mass index and mortality among non-smoking older persons: the Framingham Heart Study. JAMA 1988; 259: 1520-1524.
10. Lee IM, Manson JE, Hennekens CH, Paffenbarger RS, Jr. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 1993; 270: 2823-2828.
11. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Haeth CW, Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
12. Rosembaum M, Leiben RL, Hirsch J. Obesity. N Engl J Med 1997; 337: 396-407.
13. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox or recverse epidemiology? Eur Heart J 2005; 26: 5-7
14. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001; 258: 2486-2497.
15. Alexander CM, Landsman PB, Teutsch SM, et al. For the Third National and Nutrition Examination Survey (NHANES III), National Cholesterol Educational Program (NCEP). NCEP-defined metabolic syndrome, diabetes and prevalence of coronary artery disease among NHANES III partecipants age 50 years and older. Diabetes 2003; 52: 1210-1214.
16. Yusuf S, Hawken S, Ounpuu S, Dans T, Avenzum A, Lanas F, McQue Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet 2004; 364: 937-952.
17. Despres JP, Lemieux I, Proud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716-20
18. Grundy SM. Low density protein, non high density proteins, and apoprotein B as targets of lipid-lowering therapies. Circulation 2002; 106: 2526-9.
19. Eckel RM, Barouch WW, Ershow AG. Report of the National Institute oh Heart, Lung and Blood Institute, National Institute of Diabetes, and Digestive and Kidney Disease Working Group on the Pathophysiology of Obesity Associated cardiovascular Disease. Circulation 2002; 105: 2923-8.
20. Alpert MA, Terry BE, Mulekar M, Cohen MV, Masey CV, Fan TM, Panayiotou H, Mukerji V. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997; 80: 736-740.
21. Jouven X, Desnos M, Guerot C, et al. Predicting sudden death in the population. Circulation 1999; 99: 1978-1983.
22. Empana JP, Ducimetiere P, Charles MA, Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men-the Paris Prospective Study I. Circulation 2004; 110: 2781-2785.
23. Horwich TB, Fonarow GC, Hamilton MA, MacLennan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
24. Lavie CJ, Osman AF, Milani RV, Mehera MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003; 91: 891-894.
25. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE. The prognosis of heart failure in the general population: the Rotterdam Study. Eur Heart J 2001; 22: 1318-1327.
26. Davos CH, Doehner W, Rauchaus M, Cicoira M, Francis DP, Anker SD. Obesity and survival in chronic heart failure (abstr). Circulation 2000; 101 (suppl II): 876.
27. Weber MA, Neutel JM, Smith DHG. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol 2001; 37: 169-174.
28. Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 1996; 78: 642-646.
29. Gruber L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnoe EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Linsday J Jr. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002: 39: 578-584.
30. Gurm HS, Whitlow PL, Kip KE for the BARI Investigators. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. J Am Coll Cardiol 2002; 39: 834-840.
31. Powell BD, Lennon RJ, Lerman A, Bell MR, Berger PB, Higano ST, Holmes DR Jr, Rihal CS. Am J Cardiol 2003; 91: 472-476.
32. Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ. Impact of body mass index on outcomes after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 2002; 90: 42-45.
33. Kim J, Hammar N, Jakobbson K, Luepker RV, McGovern PG, Invert T. Obesity and the risk of early and late mortality after coronary by pass surgery. Am Heart J 2003; 146: 555-560.
34. Birkmeyer NJO, Charlesworth DC, Hernandez F, Leavitt BJ, Marrin CAS, Morton JR, Olmstead EM, O'Connor GT for the Northern New England Cardiovascular Disease Study Group. Circulation 1998; 97: 1689-1694.
35. Reeves BJ, Ascione R, Chamberlein MH, Angelini GD. Effect of body mass index on early outcomes in patients undergoing coronary artery by pass surgery. J Am Coll Cardiol 2003; 42: 668-676.
36. Kuduvalli M, Grayson AD, Oo AY, Fabri BM, Rashid A. The effect of obesity on mid-tenn survival following coronary artery by pass surgery. Eur J Cardiothoracic Surg 2003; 23; 368-373.
37. Klein S, Burke LE, Bray GA, Blair S, Allison DB, PiSunyer X, Hong Y, Eckel RH. Clinical implication of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association council of nutrition, physical activity and methabolism. Circulation 2004; 110: 2952-2967.